Business Context and Reporting Period
Company: InfuSystem Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 12, 2010
Event: Adoption of a Rights Agreement (Poison Pill) to protect stockholders from coercive takeover tactics.
Key Financial Metrics
This filing is a current report regarding a corporate governance action and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The Board of Directors declared a dividend of one preferred share purchase right (a "Right") for each outstanding share of common stock to stockholders of record as of November 12, 2010. This constitutes a material modification to the rights of security holders.
Guidance, Outlook, and Plan Terms
- Purpose: To ensure fair and equal treatment for all stockholders and protect against coercive takeover tactics. The Board stated it would carefully consider a fully financed offer for all shares.
- Trigger Threshold: The Rights separate from common stock and become exercisable if an "Acquiring Person" acquires 15% or more of outstanding common shares, or upon the commencement of a tender offer that would result in such ownership.
- Exercise Price: $15.00 per Unit (one one-thousandth of a share of Series A Junior Participating Preferred Shares).
- Flip-In Provision: If triggered, holders (excluding the Acquiring Person) may purchase common stock with a value equal to two times the exercise price ($30.00 worth of stock for $15.00).
- Flip-Over Provision: In the event of a merger or asset sale following a trigger, holders may purchase stock of the acquiring company with a value equal to two times the purchase price.
- Redemption: The Board may redeem the Rights for $0.001 per Right at any time before an Acquiring Person emerges.
- Expiration: The Rights expire on November 12, 2020, unless redeemed or exchanged earlier.
- Exclusions: Acquisitions by the CEO (Sean McDevitt) under specific plans and existing holders of 15% or more (unless they acquire an additional 1%) do not trigger the plan.
Investor Verification Checklist
- Verify the current trading price of InfuSystem common stock relative to the $15.00 exercise price of the Rights.
- Confirm the exact Record Date (November 12, 2010) to determine eligibility for the Rights dividend.
- Review the full Rights Agreement (Exhibit 4.1) for specific definitions of "Acquiring Person" and "Excluded Person."
- Monitor for any Board announcements regarding the redemption of the Rights or amendments to the plan.
- Check for any pending tender offers or merger discussions that could trigger the 15% threshold.